Colorectal cancer screening.
Colorectal cancer (CRC) constitutes the second leading cause of death from cancer in the United States. Increased screening for CRC have been associated with a decreased incidence in the past two decades. Continued efforts are necessary to maintain this trend. Appropriate risk stratification of individuals and compliance with recommended screening strategies are important. Colonoscopy continues to play an important role in screening; however, several different screening options are available for average-risk individuals. This article reviews the current options open to physicians to adequately screen patients for CRC based on inherit risks.
Section of Colon and Rectal Surgery, Creighton University School of Medicine, 9850 Nicholas Street, Suite 100, Omaha, NE 68114, USA.
R Scott
RS
Nelson
Alan G
AG
Thorson
D000236:Adenoma / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics / Q000517:prevention & control; D003123:Colorectal Neoplasms, Hereditary Nonpolyposis / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods*; D014481:United States